For Korean pharmaceutical and biotech companies, biosimilars used to be the new source of income. Especially after Celltrion and Samsung Bioepis successfully released biosimilars in the global market, many local pharmaceutical and biopharma firms have jumped into developing biosimilars.Chong Kun Dan
GC Biopharma said Thursday that it has released “WAPPS-Hemo,” which the company said is Korea’s first individually customized software to treat hemophilia patients.WAPPS-Hemo has the characteristics of performing the tasks of medical workers to determine the appropriate dose and interval of prescrib
A research team at Kangbuk Samsung Hospital found that acromegaly impacted the development of cardiovascular disease, including death.Acromegaly is a rare disease in which distal ends, such as hands, feet, jaw, nose, and ears, enlarge due to continuous secretion of growth hormone from the pituitary
Sanofi Aventis Korea’s labor union criticized management for using excessive and unfair discipline against workers for years and pointed to the company’s Ethics & Business Integrity (E&BI) program as the main culprit.Unionized workers claimed that the E&BI department in Korea misinterpreted the glob
The RIGHT (Research Investment for Global Health Technology) Fund said Thursday that it opened this year’s first request for proposals for Product Development Award (PDA) and Evidence Generation Award (EGA).It would receive them until Aug. 16.Both awards are research grants to support infectious dis
SK Bioscience said Wednesday that the Ministry of Food and Drug Safety approved the use of SKYCovione, the country's first homegrown Covid-19 vaccine.SKYCovione has applied GSK's immune enhancer AS03 to strengthen immune response and induce high levels of neutralizing antibodies, the company said. S
The government said Wednesday that Korea has confirmed more than 10,000 daily Covid-19 cases for the first time in 20 days.The country added 10,463 new Covid-19 infections, including 205 from overseas, bringing the total caseload to 18,349,756, the Korea Disease Control and Prevention Agency (KDCA)
A research team at Seoul National University Bundang Hospital (SNUBH) has announced the world's first successful long-term results of cochlear implantation in patients born with no cochlear for whom surgical implantation was previously unavailable.Cochlear ducts are formed during the prenatal period
Antiviral drug developer ImmuneMed said Wednesday that its candidate substance for Covid-19 treatment, burfiralimab, will soon enter into phase 3 clinical trials after receiving approval from Indonesia’s National Agency of Drug and Food Control (BPOM).The company said the Indonesian approval marked
Huons said it would supply its local anesthetic product to McKesson, a U.S. drug distribution company, through its U.S. subsidiary Huons USA.Under the accord, Huons plans to export a “5mL vial of 1 percent lidocaine hydrochloride injection,” which received U.S. Food and Drug Administration’s Abbrevi
The Ministry of Health and Welfare’s health insurance policy committee set the reimbursement price of Fexuclue (fexuprazan), a treatment for gastroesophageal reflux disease (GERD) developed by Daewoong Pharmaceutical, at 939 won ($0.73) per tablet. Fexuclue is the nation’s 34th novel drug.At a meeti
Chinese pharmaceutical companies, including Antengene, Everest Medicines, and BeiGene, established Korean offshoots recently. Unlike other Chinese companies that used to export drug ingredients to Korea, these companies aim to target the Korean market with innovative drugs for serious diseases like
CHA Healthcare, an affiliate of CHA Biotech, has acquired Fertility Specialists of Western Australia (FSWA), the largest fertility center in the region, through City Fertility, a fertility center operated by CHA Healthcare.FSWA is a fertility institution established in 2006 and has two fertility cen
With few days left until the authorization of Korea’s first homegrown Covid-19 vaccine SKYCovione, the Korean regulatory agency’s enhanced review capabilities are drawing attention.In a meeting with healthcare news reporters on Tuesday, National Institute of Food and Drug Safety Evaluation (NIFDS) D
Daewoong Pharmaceutical said it would develop a chronic skin disease treatment jointly with Scai Therapeutics, a drug delivery platform bio-venture, using transdermal absorption technology.The two companies will apply Scai Therapeutics' proprietary technology to develop a transdermal absorbable form
Bioneer, a company specializing in PCR reagents and equipment, said Wednesday that it has developed the AccuPower Monkeypox Detection Kit to detect monkeypox.The device is based on Bioneer’s patented technology, PyroHotstart. It can amplify the monkeypox virus with high sensitivity to extract the DN
Health officials said the declining trend of Covid-19 has reached its limit, predicting new infections might likely rebound in the short run."We think that the decline in the spread of Covid-19 of the past few weeks has reached its limit," said Im Sook-young, a senior official at the Central Disease
Novartis Korea said Tuesday that it obtained permission from the Ministry of Food and Drug Safety on June 9, to market Scemblix to treat adults with chronic myeloid leukemia who had received two or more tyrosine kinase inhibitors (TKI).Chronic myeloid leukemia is a malignant blood disease caused by
Hanmi Pharmaceutical said it would exclusively distribute Alivecor’s KardiaMobile 6L, a mobile electrocardiograph that can easily measure electrocardiograms using smartphones and stick-type devices, to clinic-level medical institutions nationwide.The device measures the electrocardiogram by touching
Helixmith has decided to postpone announcing the interim results of the U.S. phase 3 clinical trial for diabetic peripheral neuropathy (DPN) using its new gene therapy, Engensis (VM202), until next month, its top manager said.The company had planned to share the results of the Independent Data Monit